Docoh
Loading...

TXMD TherapeuticsMD

News

From Benzinga Pro
Stocks That Hit 52-Week Lows On Friday
14 Jan 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
During Friday's session, 445 companies made new 52-week lows.
23 Stocks Moving in Thursday's Pre-Market Session
6 Jan 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) rose 54.3% to $0.9490 in pre-market trading after declining more than 11% on Wednesday.
45 Biggest Movers From Yesterday
5 Jan 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55.
12 Health Care Stocks Moving In Tuesday's After-Market Session
4 Jan 22
Movers
Gainers
Mid-Afternoon Market Update: Dow Jumps 250 Points; Avrobio Shares Slide
4 Jan 22
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Toward the end of trading Tuesday, the Dow traded up 0.70% to 36,839.62 while the NASDAQ fell 1.57% to 15,583.77. The S&P also fell, dropping 0.03% to 4,794.93.
12 Health Care Stocks Moving In Tuesday's Intraday Session
4 Jan 22
Movers
Mid-Day Market Update: Nasdaq Dips 250 Points; TherapeuticsMD Shares Surge
4 Jan 22
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Midway through trading Tuesday, the Dow traded up 0.66% to 36,827.65 while the NASDAQ fell 1.63% to 15,574.50. The S&P also fell, dropping 0.08% to 4,792.93.
34 Stocks Moving In Tuesday's Mid-Day Session
4 Jan 22
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) jumped 31.7% to $0.5185 after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women with vasomotor symptoms due to menopause.
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
4 Jan 22
Pre-Market Outlook, Markets, Movers
23 Stocks Moving in Tuesday's Pre-Market Session
4 Jan 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 62.1% to $1.05 in pre-market trading as the company issued a clinical and corporate update.
FDA Approves TherapeuticsMD's Low Dose Bijuva
4 Jan 22
Biotech, Long Ideas, News, Penny Stocks, Health Care, FDA, Movers, Trading Ideas, General
TherapeuticsMD Inc (NASDAQ: TXMD) is trading sharply higher after it announced that the
12 Health Care Stocks Moving In Tuesday's After-Market Session
14 Dec 21
Movers
Gainers
59 Biggest Movers From Yesterday
14 Dec 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers SeaChange International, Inc. (NASDAQ: SEAC) jumped 128.8% to $1.72 following Bloomberg report suggesting that social video app Triller is in merger talks with Seachange.
40 Stocks Moving In Monday's Mid-Day Session
13 Dec 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction.
12 Health Care Stocks Moving In Monday's Intraday Session
13 Dec 21
Movers
Gainers
12 Health Care Stocks Moving In Monday's Pre-Market Session
13 Dec 21
Pre-Market Outlook, Markets, Movers
22 Stocks Moving in Monday's Pre-Market Session
13 Dec 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 32.6% to $3.58 in pre-market trading after gaining more than 14% on Friday.
TherapeuticsMD's Birth Control Med Receives FDA Response Letter To Revise Manufacturing Testing Limits
13 Dec 21
Biotech, News, Penny Stocks, Health Care, FDA, Movers, Trading Ideas, General
TherapeuticsMD Reports FDA 'determined that it could not approve proposed revisions to the manufacturing testing limits requested through the Supplemental New Drug Application'
10 Dec 21
Biotech, News, FDA, General
- FDA determined that it could not approve proposed revisions to the manufacturing testing limits requested through the Supplemental New Drug Application (sNDA) - - FDA provided recommendations and requested additional
38 Stocks Moving In Thursday's Mid-Day Session
9 Dec 21
News, Intraday Update, Markets, Movers, Trading Ideas
Gainers

Press releases

From Benzinga Pro
Thinking about buying stock in 9 Meters Biopharma, TherapeuticsMD, Cameco Corp, Nikola Corp, or Comstock Mining?
5 Jan 22
Opinion, Press Releases
NEW YORK, Jan. 5, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NMTR, TXMD, CCJ, NKLA, and LODE.
Thinking about buying stock in Genprex, TherapeuticsMD, Soligenix, Norwegian Cruise Line, or Zomedica?
4 Jan 22
Opinion, Press Releases
NEW YORK, Jan. 4, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GNPX, TXMD, SNGX, NCLH, and ZOM.
U.S. Food and Drug Administration (FDA) Responds to Request From TherapeuticsMD to Revise Certain Manufacturing Testing Limits for ANNOVERA®
10 Dec 21
Press Releases
- FDA determined that it could not approve proposed revisions to the manufacturing testing limits requested through the Supplemental New Drug Application (sNDA) - - FDA provided recommendations and requested additional
TherapeuticsMD Settles U.S. Patent Litigation with Amneal for BIJUVA® (Estradiol and Progesterone) — Allowing for a May 25, 2032 Generic Entry Date
8 Dec 21
Press Releases
TherapeuticsMD, Inc. (NASDAQ:TXMD), an innovative, leading women's healthcare company, today announced the settlement of the previously disclosed U.S. patent litigation for BIJUVA® with Amneal Pharmaceuticals,
TherapeuticsMD Announces Third Quarter 2021 Financial Results
11 Nov 21
Press Releases
- Quarterly total net product revenue of $24.5 million, an increase of 41.1% over Q3 2020 - - ANNOVERA® TRx of 8,351, an increase of 62.7% over Q3 2020 - - Cost savings initiative to reduce SG&A by $40
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O'Dowd, as Chief Executive Officer
11 Nov 21
Press Releases
- Mr. O'Dowd to succeed Robert G. Finizio, effective on or before December 31, 2021 - - Mr. Finizio appointed Vice Chair of the Board - TherapeuticsMD, Inc. (NASDAQ:TXMD) (TXMD or the Company), an innovative, leading
TherapeuticsMD to Report Third Quarter 2021 Results on November 11, 2021
27 Oct 21
Press Releases
-Executive Management to Host Conference Call on November 11, 2021 at 8:30 a.m. ET- TherapeuticsMD, Inc. (NASDAQ:TXMD) ("TXMD" or the "Company"), an innovative, leading women's healthcare company, today announced that